Home > Healthcare > Biotechnology > Biotechnology R&D > Prenatal and New-born Genetic Testing Market

Prenatal and New-born Genetic Testing Market Share

Report ID: GMI1906
Published Date: Jun 2021
Report Format: PDF

Download Free Sample

Prenatal and New-born Genetic Testing Market Share

Some of the major companies operating in the prenatal and new-born genetic testing market are

Ariosa Diagnostics (Roche)
Berry Genomics
BGI
Biorad
Illumina
Laboratory Corporation of America
Natera
Qiagen
Sequenom
Trivitron Healthcare
Verinata Health

These major participants emphasize on strategic initiatives including collaborations, acquisitions, new product launch and commercialization for market development. Moreover, these firms heavily invest in research and development that enables them to introduce innovative products and garner maximum revenue.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Prenatal and newborn genetic testing market size was valued at USD 4.5 billion in 2020 and could expand at a CAGR of more than 11.5% through 2027.

The demand for prenatal and newborn genetic screening could increase at a CAGR of 11.4% through 2027 led by constant technological advances, growing awareness regarding birth defects, and surge in the use of screening during pregnancy.

Down’s syndrome held over 41% revenue share of prenatal and newborn genetic testing market in 2020 and the segment could grow at an 11.4% CAGR up to 2027.

Prenatal and newborn genetic testing industry share from hospitals surpassed USD 2.1 billion in 2020.

U.S. prenatal and newborn genetic testing market could register gains at a CAGR of over 10.3% over 2021-2027.